期刊文献+

B淋巴细胞在类风湿关节炎中的致病作用 被引量:2

原文传递
导出
摘要 长期以来,类风湿性滑膜炎(rheumatoid synovitis)仅被看作是一种抗原非依赖的慢性炎症过程,在类风湿关节炎(rheumatoid arthritis,RA)的发病中扮演次要作用。近来,随着发现T细胞和B细胞在滑膜组织中呈现寡克隆扩增和B细胞能进行局灶性生发中心(germinal center,Gc)反应。以前曾被认为是RA非特异性区域的滑膜组织逐渐演变成为一个能进行特异性免疫反应(可以发展成异位淋巴样组织,ectopic lymphoid tissue)的部位,滑膜已被认为是RA中一种最相关的致病性组织。
出处 《中华风湿病学杂志》 CAS CSCD 2006年第9期566-570,共5页 Chinese Journal of Rheumatology
  • 相关文献

参考文献18

  • 1Shiokawa S,Matsumato N,Nishimura J.Clonal analysis of B cells in the synovial membrane of patients with rheumatoid arthritis.Scand J Rheumatol,2003,32:12-18.
  • 2奚正德,张冬青.骨保护蛋白对类风湿疾病相关骨吸收的作用[J].国外医学(免疫学分册),2005,28(6):338-341. 被引量:7
  • 3奚正德,李宁丽,张雁云,张冬青,臧敬五.滑膜成纤维细胞在关节炎发病中的作用[J].自然杂志,2004,26(4):205-209. 被引量:15
  • 4奚正德,王利,柏峻,张继英,沈佰华,余奇文,张雁云,张冬青.Ⅱ型胶原特异性T细胞系与关节炎发病机制的研究[J].中华风湿病学杂志,2003,7(9):527-530. 被引量:25
  • 5Edwards JC,Szczepanski L,Szechinski J,et al.Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.New Engl J Med,2004,350:2572-2581.
  • 6Reparon-Schuijt CC,van Esch WJ,van Kooten C,et al.Presence of a population of CD20^+,CD38^-B lymphocytes with defective proliferative responsiveness in the synovial compartment of patients with rheumatoid arthritis.Arthritis Rheum,2001,44:2029-2037.
  • 7奚正德.来氟米特和细胞因子抑制剂在类风湿性关节炎治疗中的应用进展[J].临床药物治疗杂志,2006,4(3):16-22. 被引量:5
  • 8Carayannopoulos MO,Potter KN,Li Y,et al.Evidence that human immunoglobulin M rheumatoid factors can be derived from the natural autoantibody pool and undergo an antigen driven immune response in which somatically mutated rheumatoid factors have lower affinities for immunoglobulin G Fc than their germline counterparts.Scand J Immunol,2000,51:327-336.
  • 9Schubert D,Schmidt M,Zaiss D,et al.Autoantibodies to GPI and creatine kinase in RA.Nat Immunol,2002,3:411-413.
  • 10Menard HA,Lapointe E,Rochdi MD,et al.Insights into rheumatoid arthritis derived from the Sa immune system.Arthritis Res,2000,2:429-432.

二级参考文献70

  • 1奚正德,马宝骊.类风湿性关节炎的骨髓源学说[J].自然杂志,1998,20(6):318-322. 被引量:7
  • 2奚正德,李宁丽,张雁云,张冬青,臧敬五.滑膜成纤维细胞在关节炎发病中的作用[J].自然杂志,2004,26(4):205-209. 被引量:15
  • 3奚正德,张冬青.关节炎性骨侵蚀和骨保护蛋白的作用[J].自然杂志,2004,26(6):324-327. 被引量:9
  • 4[25]Fleischmann RM,Schechtman J,Bennett R,et al.Anakinra,a recombinant human interleukin-1 receptor antagonist (rmetHuIL-1ra),in patients with rheumatoid arthritis:A large,international,multicenter,placebo-controlled trial.Arthritis Rheum,2003,48 (4):927-934
  • 5[2]Xi Z,Zhang J,Shen B,et al.Type Ⅱ collagen-specific T cells mediate the onset of arthritis.US.Chin J Lymphology Oncol,2004,3 (4):198-202
  • 6[6]Felson DT,Anderson JJ,Boers M,et al.American College of Rheumatology.Preliminary definition of improvement in rheumatoid arthritis.Arthritis Rheum,1995,38 (6):727-735
  • 7[7]Smolen JS,Kalden JR,Scott DL,et al.Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis:a double-blind,randomised,multicentre trial.European Leflunomide Study Group.Lancet,1999,353(9149):259-266
  • 8[8]Strand V,Cohen S,Schiff M,et al.Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate.Leflunomide Rheumatoid Arthritis Investigators Group.Arch Intern Med,1999,159 (21):2542-2550
  • 9[9]Cohen S,Cannon GW,Schiff M,et al.Two-year,blinded,randomized,controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate.Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.Arthritis Rheum,2001,44 (9):1984-1992
  • 10[10]Lee H,Kimko HC,Rogge M.Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis.Clin Pharmacol Ther,2003,73 (4):348-365

共引文献40

同被引文献18

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部